Skip to content
Screener

Thermo Fisher Scientific TMO Comprehensive Income (Loss), Net of Tax, Attributable to Parent

Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies

Revvity logo
RevvityRVTY
$48.82M-77.1%
TEC
Bio-TechneTECH
$46.54M+77.7%
Mettler-Toledo International, Inc. logo
Mettler-Toledo International, Inc.MTD

Other financials

Income statement

See full
Revenue$12.0B
Operating income$2.1B
Net income$1.7B+7.4%
EPS (diluted)$4.68+9.3%

Balance sheet

See full
Cash & equivalents$4.1B-11.7%
Total debt$39.2B+4.6%
Total equity$52.7B+4.3%
Total assets$113.17B+11.8%

Cash flow

See full
Operating cash flow$2.1B+51.9%
CapEx-$1.2B-509%
Free cash flow$923.0M-16.5%

Valuation

See full
Market cap$219.63B+25.8%
Enterprise value$254.75B+22.8%
P/E31.5×+5.0×
P/S4.9×-1.0×

Profitability

See full
Gross margin58.3%
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp
FCF margin15.7%-2.1pp

Returns & leverage

See full
Return on equity13.5%+0.1pp
Debt / equity0.7×0.0×
Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.

The source filing: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 11:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000097745-26-000092
(In millions)Three months ended / March 28, 2026March 29, 2025
Reclassification adjustment for losses included in net income (net of tax (provision) benefit of $0 and $0)11
Pension and other postretirement benefit liability adjustments:
Pension and other postretirement benefit liability adjustments arising during the period (net of tax (provision) benefit of $(1) and $1)2(3)
Amortization of net loss included in net periodic pension cost (net of tax (provision) benefit of $0 and $0)11
Total other comprehensive income/(loss)(55)358
Comprehensive income/(loss)1,6011,869
Less: comprehensive income/(loss) attributable to noncontrolling interests and redeemable noncontrolling interest(1)8
Comprehensive income attributable to Thermo Fisher Scientific Inc.$1,602$1,861

Item 1. Financial Statements (Unaudited)

FAQ

What is Thermo Fisher Scientific's comprehensive income (loss), net of tax, attributable to parent?
Thermo Fisher Scientific (TMO) reported comprehensive income (loss), net of tax, attributable to parent of $1.6B in Q1 2026.
How has Thermo Fisher Scientific's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
Thermo Fisher Scientific's comprehensive income (loss), net of tax, attributable to parent decreased by 13.9% year-over-year, from $1.86B to $1.6B.

Ask your AI about Thermo Fisher Scientific's comprehensive income (loss), net of tax, attributable to parent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude